Authors:
Bron, AM
Denis, P
Nordmann, JP
Rouland, JF
Sellem, E
Johansson, M
Citation: Am. Bron et al., Additive IOP-reducing effect of latanoprost in patients insufficiently controlled on timolol, ACT OPHTH S, 79(3), 2001, pp. 289-293
Authors:
Goldberg, I
Cunha-Vaz, J
Jakobsen, JE
Nordmann, JP
Trost, E
Sullivan, EK
Citation: I. Goldberg et al., Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension, J GLAUCOMA, 10(5), 2001, pp. 414-422
Authors:
Roussat, B
Gohier, P
Doummar, D
Iba-Zizen, MT
Barbat, V
Jarry, D
Cabanis, EA
Hamard, H
Nordmann, JP
Citation: B. Roussat et al., Acute optic neuritis in children: clinical features and treatment. A studyof 20 cases (28 eyes), J FR OPHTAL, 24(1), 2001, pp. 36-44
Authors:
Baudouin, C
Bechetoille, A
Bron, A
Denis, P
Nordmann, JP
Renard, JP
Rouland, JF
Sellem, E
Rigeade, MC
Arnould, B
Citation: C. Baudouin et al., Relevance of quality of life and treatment compliance measurement in patients with chronic open-angle glaucoma, J FR OPHTAL, 23(10), 2000, pp. 1057-1064
Authors:
Nordmann, JP
Soderstrom, M
Rouland, JF
Malecaze, F
Citation: Jp. Nordmann et al., Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists, BR J OPHTH, 84(2), 2000, pp. 181-185
Citation: Jp. Nordmann et al., A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF(2 alpha) metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension, CURR MED R, 15(2), 1999, pp. 87-93